Vanguard Group Inc Gbs Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.0 - $0.47 $0 - $217	462 Added 2.81%	16,916 $0
Q2 2022 Aug 12, 2022	BUY	$0.56 - $1.31 $9,214 - $21,554	16,454 New	16,454 $11,000
Q1 2022 May 13, 2022	SELL	$0.43 - $1.7 $16,737 - $66,172	-38,925 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.26 - $2.45 $18,906 - $36,762	15,005 Added 62.73%	38,925 $56,000
Q3 2021 Nov 12, 2021	BUY	$2.26 - $4.29 $11,449 - $21,733	5,066 Added 26.87%	23,920 $61,000

Q2 2021 Aug 13, 2021	BUY	$2.65 - $5.72 $49,963 - $107,844	18,854 New	18,854 $74,000

Ticker GBS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,889,900
Description
GBS Inc. operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company also focuses on developing COV2 test, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, t...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.